» Articles » PMID: 26352880

HIV Acquisition During Pregnancy and Postpartum is Associated with Genital Infections and Partnership Characteristics

Overview
Journal AIDS
Date 2015 Sep 10
PMID 26352880
Citations 62
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The objective of this study is to determine the risk and cofactors for HIV acquisition during pregnancy and postpartum.

Design: A prospective cohort study

Methods: : Pregnant women in western Kenya were enrolled if HIV seronegative at that visit or within 3 months. Serial HIV nucleic acid amplification tests (NAATs) were conducted at 1 to 3-month intervals to 9 months postpartum. Genital swabs were collected for detection of chlamydia and gonorrhoea at baseline, and for trichomonas, bacterial vaginosis and yeast at baseline and follow-up.

Results: Among 1304 pregnant women, median age was 22 years, 78% were married for a median of 4 years, 66% reported knowing partner HIV status and 8% reported using condoms. Study retention was 98%. During 1235 person-years of follow-up, HIV incidence was 2.31/100 person-years [95% confidence interval (95% CI) 0.71-4.10]. Incident HIV was associated with syphilis (hazard ratio 9.18, 95% CI 2.15-39.3), chlamydia (hazard ratio 4.49, 95% CI 1.34-15.0), bacterial vaginosis (hazard ratio 2.91, 95% CI 1.25-6.76), yeast (hazard ratio 3.46, 95% CI 1.46-8.19), sexually transmitted infection (STI) history (hazard ratio 3.48, 95% CI 1.31-9.27), lifetime number of sex partners (hazard ratio 1.19, 95% CI 1.03-1.37), partner age discordance (hazard ratio 1.07 per year, 95% CI 1.02-1.13) and shorter marriage (hazard ratio 1.19 per year, 95% CI 1.03-1.38). No women with incident HIV reported an HIV-infected partner. In multivariate analyses, chlamydia, older partners and yeast infection remained significant; however, power was limited.

Conclusion: Pregnant and lactating women may not perceive HIV risk and rarely used condoms. Prevention and treatment of genital infections and risk stratification to identify women for pre-exposure prophylaxis (PrEP) could decrease HIV acquisition in pregnant/lactating women.

Citing Articles

The effect of STI screening during pregnancy on vertical transmission of HIV and adverse pregnancy outcomes in South Africa: a modelling study.

Nyemba D, Joseph-Davey D, Delany-Moretlwe S, Myer L, Johnson L J Int AIDS Soc. 2025; 28(2):e26410.

PMID: 39865475 PMC: 11769709. DOI: 10.1002/jia2.26410.


Maternal HIV retesting during antenatal care in selected health facilities in Mayuge district, Uganda: A cross-sectional study.

Kayiwa F, Nabiwemba E, Bunani N, Ndejjo R PLOS Glob Public Health. 2025; 5(1):e0004173.

PMID: 39813258 PMC: 11734972. DOI: 10.1371/journal.pgph.0004173.


Predictors of maternal HIV acquisition during pregnancy and lactation in sub-Saharan Africa: A systematic review and narrative synthesis.

Graybill L, Chi B, Hamoonga T, Kasaro M, Hodges J, Richardson B PLoS One. 2024; 19(12):e0314747.

PMID: 39625969 PMC: 11614209. DOI: 10.1371/journal.pone.0314747.


Evaluating the performance of a risk assessment score tool to predict HIV acquisition among pregnant and postpartum women in Kenya.

Chhun N, Rothschild C, Penumetsa M, Matemo D, Kithao P, Richardson B PLoS One. 2024; 19(7):e0306992.

PMID: 38985777 PMC: 11236202. DOI: 10.1371/journal.pone.0306992.


Drug Concentrations in Hair and Dried Blood Spots as Preexposure Prophylaxis Adherence Metrics During Pregnancy and Postpartum.

Wu L, Kinuthia J, Anderson P, Baeten J, Dettinger J, Gandhi M J Infect Dis. 2024; 230(3):689-695.

PMID: 38700101 PMC: 11420739. DOI: 10.1093/infdis/jiae208.


References
1.
Pilcher C, McPherson J, Leone P, Smurzynski M, Owen-ODowd J, Harris J . Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. JAMA. 2002; 288(2):216-21. DOI: 10.1001/jama.288.2.216. View

2.
H Gray R, Li X, Kigozi G, Serwadda D, Brahmbhatt H, Wabwire-Mangen F . Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study. Lancet. 2005; 366(9492):1182-8. DOI: 10.1016/S0140-6736(05)67481-8. View

3.
Kinuthia J, Kiarie J, Farquhar C, Richardson B, Nduati R, Mbori-Ngacha D . Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res. 2010; 8(7):510-4. PMC: 3372399. DOI: 10.2174/157016210793499213. View

4.
Wira C, Fahey J, Rodriguez-Garcia M, Shen Z, Patel M . Regulation of mucosal immunity in the female reproductive tract: the role of sex hormones in immune protection against sexually transmitted pathogens. Am J Reprod Immunol. 2014; 72(2):236-58. PMC: 4351777. DOI: 10.1111/aji.12252. View

5.
Onah H, Iloabachie G, Obi S, Ezugwu F, Eze J . Nigerian male sexual activity during pregnancy. Int J Gynaecol Obstet. 2002; 76(2):219-23. DOI: 10.1016/s0020-7292(01)00579-3. View